PenRadTM Moves Beyond Mammography, Extends New Platform to Healthcare
Buffalo, MN, December 2, 2013 – PenRad, market leader in Mammography Information Systems (MIS), today announced an expanded product portfolio beyond breast imaging. PenRad’s next generation offerings include solutions for the continuum of radiology and healthcare informatics. Highlights include zero-footprint multi- platform technology including tablets, goal-oriented ICD10 and SNOMED coding, a controlled natural language engine, CT lung nodule tracking, and 3-D visualization from 2D US scans of the carotid lumen.
PenRad President and CEO, Greg Gustafson says, “as the pioneer in workflow automation, structured reporting and professional productivity, our clients have requested that we apply our knowledge to other healthcare disciplines.” Gustafson goes on to say, “PenRad has developed a new programming paradigm optimizing healthcare informatics beyond what is presently available. PenRad will be hosting a number of OEM vendors to discuss licensing opportunities at the upcoming RSNA.”
All product offerings will be on display at this year’s RSNA, McCormick Place, Chicago IL, December 1st – 6th, Booth 3100.
About PenRad
Founded in 1995, PenRad’s suite of innovative software products enhances professional productivity and workflow, quality and revenue in radiology and cardiology image and information management. PenRad’s portfolio of software products includes information systems for women’s imaging and the vascular lab; providing fast, reliable, secure tracking, reporting and management of critical patient data. Additional software products include PenViewTM diagnostic reading station and CompassTM for breast MRI analysis. PenRad also offers integrations with various cancer risk analysis algorithms, breast density software, CAD, BMD analysis, softcopy synchronization and RIS/HIS/PACS systems. PenRad partners with customers to optimize workflow by integrating with existing infrastructures or providing a complete solution. Visit http://www.penrad.com for more information.